
According to data from Benzinga Pro, during Q4, Seattle Genetics's (NASDAQ:SGEN) reported sales totaled $429.85 million. Despite a 40.57% increase in earnings, the company posted a loss of $174.63 million. In Q3, Seattle Genetics brought in $424.06 million in sales but lost $293.85 million in earnings.